• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TCF7通过增强应激自然杀伤细胞及其与肺动脉平滑肌细胞的相互作用来加重肺动脉高压。

TCF7 enhances pulmonary hypertension by boosting stressed natural killer cells and their interaction with pulmonary arterial smooth muscle cells.

作者信息

Wu Li-Wei, Chen Min, Jiang Dai-Ji, Jiang Chen-Yu, Liu Yi-Wei, Feng Bei, Shi Chen-Fei, Huang Xu, Zhang Xu, Xu Xiao-He, Zhou Xing-Liang, Shen Yi, Liu Tian-Yu, Ye Lin-Cai, He Yang-Yang, Zhang Hao, Yan Yi

机构信息

Heart Center and Shanghai Institute of Pediatric Congenital Heart Disease, Shanghai Children's Medical Center, National Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Shanghai Clinical Research Center for Rare Pediatric Diseases, Shanghai Children's Medical Center, National Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Respir Res. 2025 May 29;26(1):202. doi: 10.1186/s12931-025-03276-9.

DOI:10.1186/s12931-025-03276-9
PMID:40442690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12121176/
Abstract

BACKGROUND

Pulmonary hypertension (PH) is a life-threatening cardio-pulmonary disorder. Whether natural killer (NK) cells could act as participants in PH and the mechanism by which NK cells moderate pulmonary vascular remodeling has not been fully elucidated.

METHODS

Single-cell RNA sequencing data from lungs of human pulmonary arterial hypertension (PAH) patients and monocrotaline (MCT)-induced PH rat model were retrieved from GEO database or UCSC Cell Browser. Tcf7 conditional knockout mice and TCF7 overexpression following adeno-associated virus 6 (AAV6) intratracheal delivery in rats were generated. The NK92 cell line and primary human pulmonary artery smooth muscle cells (hPASMCs) were used for in vitro experiments.

RESULTS

Stressed NK cells were much higher in lungs from human PAH and MCT-induced PH compared to corresponding controls. Of note, TCF7 topped the list differentiating high-stressed from low-stressed human NK cells. TCF7-expressing NK cells displayed higher stress profile than TCF7-deficient cells. Tcf7-deficient NK cells exhibited lower Hsp90aa1 and Hsp90ab1 at transcriptional level and Hsp90 at protein level than Tcf7-expressing cells 24 h post-hypoxia. Mechanistically, TCF7-overexpressing NK cells secrete more SPP1 compared to control NK cells, thus promoting the proliferation and migration of hPASMCs 48 h post-hypoxia. TCF7 overexpression in rats aggravated PH features, while Tcf7 deficiency in mice alleviated pulmonary remodeling possibly due to the manipulation of HSP90 level in NK cells and SPP1 in the microenvironment.

CONCLUSIONS

TCF7 contributes to the immunopathology of PH possibly through upregulation of stressed NK cells. Under stress conditions, NK cells promote the proliferation and migration of hPASMC through paracrine effects, thereby further promoting vascular remodeling.

摘要

背景

肺动脉高压(PH)是一种危及生命的心肺疾病。自然杀伤(NK)细胞是否可作为PH的参与者,以及NK细胞调节肺血管重塑的机制尚未完全阐明。

方法

从基因表达综合数据库(GEO数据库)或加州大学圣克鲁兹分校细胞浏览器中检索人类肺动脉高压(PAH)患者肺部以及野百合碱(MCT)诱导的PH大鼠模型的单细胞RNA测序数据。构建Tcf7条件性敲除小鼠,并通过腺相关病毒6(AAV6)气管内注射使大鼠过表达TCF7。使用NK92细胞系和原代人肺动脉平滑肌细胞(hPASMCs)进行体外实验。

结果

与相应对照组相比,人类PAH和MCT诱导的PH患者肺部的应激NK细胞数量明显更多。值得注意的是,在区分高应激和低应激人类NK细胞方面,TCF7位居榜首。表达TCF7的NK细胞比缺乏TCF7的细胞表现出更高的应激特征。缺氧24小时后,缺乏Tcf7的NK细胞在转录水平上的Hsp90aa1和Hsp90ab1以及蛋白质水平上的Hsp90均低于表达Tcf7的细胞。从机制上讲,与对照NK细胞相比,过表达TCF7的NK细胞分泌更多的SPP1,从而在缺氧48小时后促进hPASMCs的增殖和迁移。大鼠中TCF7的过表达加剧了PH特征,而小鼠中Tcf7的缺乏减轻了肺重塑,这可能是由于对NK细胞中HSP90水平和微环境中SPP1的调控所致。

结论

TCF7可能通过上调应激NK细胞而促进PH的免疫病理学发展。在应激条件下,NK细胞通过旁分泌作用促进hPASMCs的增殖和迁移,从而进一步促进血管重塑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f4a/12121176/8f1e7bfb5b2d/12931_2025_3276_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f4a/12121176/a89614d97dca/12931_2025_3276_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f4a/12121176/533da1300378/12931_2025_3276_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f4a/12121176/6fc918e418c8/12931_2025_3276_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f4a/12121176/c03a54199854/12931_2025_3276_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f4a/12121176/46b0dbd4caba/12931_2025_3276_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f4a/12121176/d03f9817a6ce/12931_2025_3276_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f4a/12121176/8f1e7bfb5b2d/12931_2025_3276_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f4a/12121176/a89614d97dca/12931_2025_3276_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f4a/12121176/533da1300378/12931_2025_3276_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f4a/12121176/6fc918e418c8/12931_2025_3276_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f4a/12121176/c03a54199854/12931_2025_3276_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f4a/12121176/46b0dbd4caba/12931_2025_3276_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f4a/12121176/d03f9817a6ce/12931_2025_3276_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f4a/12121176/8f1e7bfb5b2d/12931_2025_3276_Fig7_HTML.jpg

相似文献

1
TCF7 enhances pulmonary hypertension by boosting stressed natural killer cells and their interaction with pulmonary arterial smooth muscle cells.TCF7通过增强应激自然杀伤细胞及其与肺动脉平滑肌细胞的相互作用来加重肺动脉高压。
Respir Res. 2025 May 29;26(1):202. doi: 10.1186/s12931-025-03276-9.
2
HMGB2 Release Promotes Pulmonary Hypertension and Predicts Severity and Mortality of Patients With Pulmonary Arterial Hypertension.HMGB2释放促进肺动脉高压并预测肺动脉高压患者的严重程度和死亡率。
Arterioscler Thromb Vasc Biol. 2024 Jun;44(6):e172-e195. doi: 10.1161/ATVBAHA.123.319916. Epub 2024 Apr 4.
3
PAR-2 inhibition reverses experimental pulmonary hypertension.PAR-2 抑制可逆转实验性肺动脉高压。
Circ Res. 2012 Apr 27;110(9):1179-91. doi: 10.1161/CIRCRESAHA.111.257568. Epub 2012 Mar 29.
4
SMYD2-Methylated PPARγ Facilitates Hypoxia-Induced Pulmonary Hypertension by Activating Mitophagy.SMYD2 甲基化的过氧化物酶体增殖物激活受体 γ 通过激活线粒体自噬促进低氧诱导的肺动脉高压。
Circ Res. 2024 Jun 21;135(1):93-109. doi: 10.1161/CIRCRESAHA.124.323698. Epub 2024 May 21.
5
5-Aminoimidazole-4-carboxamide ribonucleotide formyltransferase/inosine monophosphate cyclohydrolase promotes pulmonary arterial smooth muscle cell proliferation via the Ras signaling pathway.5-氨基咪唑-4-甲酰胺核糖核苷酸甲酰基转移酶/肌苷单磷酸环水解酶通过Ras信号通路促进肺动脉平滑肌细胞增殖。
Am J Physiol Cell Physiol. 2024 Oct 1;327(4):C901-C912. doi: 10.1152/ajpcell.00262.2024. Epub 2024 Aug 12.
6
ASH2L Deficiency in Smooth Muscle Drives Pulmonary Vascular Remodeling.平滑肌中ASH2L缺乏导致肺血管重塑。
Circ Res. 2025 Mar 28;136(7):719-734. doi: 10.1161/CIRCRESAHA.124.325539. Epub 2025 Feb 25.
7
Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.阻断 JAK2 可通过抑制肺动脉平滑肌细胞增殖来保护小鼠免受低氧诱导的肺动脉高压。
Cell Prolif. 2020 Feb;53(2):e12742. doi: 10.1111/cpr.12742. Epub 2020 Jan 14.
8
Piezo1 in PASMCs: Critical for Hypoxia-Induced Pulmonary Hypertension Development.肺动脉平滑肌细胞中的Piezo1:对缺氧诱导的肺动脉高压发展至关重要。
Circ Res. 2025 Apr 25;136(9):1031-1048. doi: 10.1161/CIRCRESAHA.124.325475. Epub 2025 Apr 4.
9
MrgD as a Novel Modeling and Treatment Target for Pulmonary Hypertension.MrgD作为肺动脉高压的新型建模与治疗靶点
Arterioscler Thromb Vasc Biol. 2025 May;45(5):e164-e183. doi: 10.1161/ATVBAHA.124.322337. Epub 2025 Mar 27.
10
lncRNA VELRP Modulates Pulmonary Arterial Smooth Muscle Cell Proliferation and Promotes Vascular Remodeling in Pulmonary Hypertension.长链非编码 RNA VELRP 调节肺动脉平滑肌细胞增殖并促进肺动脉高压中的血管重塑。
Arterioscler Thromb Vasc Biol. 2024 Dec;44(12):2560-2576. doi: 10.1161/ATVBAHA.124.321416. Epub 2024 Oct 3.

本文引用的文献

1
Quercetin regulates pulmonary vascular remodeling in pulmonary hypertension by downregulating TGF-β1-Smad2/3 pathway.槲皮素通过下调 TGF-β1-Smad2/3 通路调节肺动脉高压肺血管重构。
BMC Cardiovasc Disord. 2024 Oct 4;24(1):535. doi: 10.1186/s12872-024-04192-4.
2
The CEBPB glioblastoma subcluster specifically drives the formation of M2 tumor-associated macrophages to promote malignancy growth.CEBPB 胶质母细胞瘤亚群特异性地驱动 M2 肿瘤相关巨噬细胞的形成,从而促进恶性肿瘤生长。
Theranostics. 2024 Jul 2;14(10):4107-4126. doi: 10.7150/thno.93473. eCollection 2024.
3
Microglial- neuronal crosstalk in chronic viral infection through mTOR, SPP1/OPN and inflammasome pathway signaling.
慢性病毒感染中通过mTOR、SPP1/OPN和炎性小体途径信号传导的小胶质细胞-神经元相互作用。
Front Immunol. 2024 Apr 5;15:1368465. doi: 10.3389/fimmu.2024.1368465. eCollection 2024.
4
BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension.BRCC3 调控血管平滑肌细胞中的 ALK2:在肺动脉高压中的意义。
Circulation. 2024 Jul 9;150(2):132-150. doi: 10.1161/CIRCULATIONAHA.123.066430. Epub 2024 Apr 1.
5
Natural killer cell therapies.自然杀伤细胞疗法。
Nature. 2024 Feb;626(8000):727-736. doi: 10.1038/s41586-023-06945-1. Epub 2024 Feb 21.
6
Pulmonary hypertension.肺动脉高压
Nat Rev Dis Primers. 2024 Jan 4;10(1):1. doi: 10.1038/s41572-023-00486-7.
7
A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates the immune cells.一种新型 PDPN 拮抗剂肽 CY12-RP2 通过 Wnt/β-catenin 抑制黑色素瘤生长,并调节免疫细胞。
J Exp Clin Cancer Res. 2024 Jan 2;43(1):9. doi: 10.1186/s13046-023-02910-y.
8
Associations of cortical SPP1 and ITGAX with cognition and common neuropathologies in older adults.老年人皮质 SPP1 和 ITGAX 与认知和常见神经病理学的关联。
Alzheimers Dement. 2024 Jan;20(1):525-537. doi: 10.1002/alz.13474. Epub 2023 Sep 19.
9
A pan-cancer single-cell panorama of human natural killer cells.人类自然杀伤细胞的泛癌症单细胞全景图。
Cell. 2023 Sep 14;186(19):4235-4251.e20. doi: 10.1016/j.cell.2023.07.034. Epub 2023 Aug 21.
10
Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management.肺部疾病相关肺动脉高压:病理机制、诊断和治疗新见解。
Lancet Respir Med. 2023 Sep;11(9):820-835. doi: 10.1016/S2213-2600(23)00259-X. Epub 2023 Aug 14.